HUT62193A - Process for producing pharmaceutical composition improving the effect of photoageing - Google Patents

Process for producing pharmaceutical composition improving the effect of photoageing

Info

Publication number
HUT62193A
HUT62193A HU906129A HU612990A HUT62193A HU T62193 A HUT62193 A HU T62193A HU 906129 A HU906129 A HU 906129A HU 612990 A HU612990 A HU 612990A HU T62193 A HUT62193 A HU T62193A
Authority
HU
Hungary
Prior art keywords
photoageing
effect
pharmaceutical composition
producing pharmaceutical
composition improving
Prior art date
Application number
HU906129A
Other languages
Hungarian (hu)
Other versions
HU906129D0 (en
Inventor
Neil Frederick Haley
Xina Nair
Gerard Joseph Gendimenico
Christopher F Zusi
Thomas R Swann
Original Assignee
Eastman Kodak Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastman Kodak Co filed Critical Eastman Kodak Co
Publication of HU906129D0 publication Critical patent/HU906129D0/en
Publication of HUT62193A publication Critical patent/HUT62193A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU906129A 1989-07-25 1990-07-19 Process for producing pharmaceutical composition improving the effect of photoageing HUT62193A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38494989A 1989-07-25 1989-07-25
US55272790A 1990-07-16 1990-07-16

Publications (2)

Publication Number Publication Date
HU906129D0 HU906129D0 (en) 1991-07-29
HUT62193A true HUT62193A (en) 1993-04-28

Family

ID=27010824

Family Applications (1)

Application Number Title Priority Date Filing Date
HU906129A HUT62193A (en) 1989-07-25 1990-07-19 Process for producing pharmaceutical composition improving the effect of photoageing

Country Status (6)

Country Link
EP (1) EP0436010A1 (en)
JP (1) JPH04500824A (en)
KR (1) KR920700612A (en)
CA (1) CA2035459A1 (en)
HU (1) HUT62193A (en)
WO (1) WO1991001128A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1000937B (en) * 1990-08-24 1993-03-16 Eastman Kodak Co Skin treatment and method for the restoration of the skin against sun effects
JPH09509403A (en) * 1993-12-15 1997-09-22 エイボン プロダクツ インコーポレイテッド Novel retinoid conjugate compounds and methods for treating skin aging
DE4421433C1 (en) * 1994-06-18 1995-06-08 Lohmann Therapie Syst Lts Transdermal therapeutic system for treatment of, e.g., hypertension
FR2767823B1 (en) * 1997-08-27 1999-10-15 Oreal COMPOUNDS DERIVED FROM AMINOPHENOL AND THEIR USE IN COSMETICS
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US7166744B2 (en) * 2001-05-29 2007-01-23 Chebigen Co., Ltd. Retinoid derivatives and methods for producing said compounds and anti-cancer pharmaceutical composition comprising said compounds
EP2319518A1 (en) 2002-02-04 2011-05-11 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Use of CO-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
PT2699242T (en) 2011-04-19 2018-01-22 Alfama Inc Carbon monoxide releasing molecules and uses thereof
ES2628634T3 (en) 2011-07-21 2017-08-03 Alfama, Inc. Carbon monoxide-ruthenium releasing molecules and uses thereof
US9229007B2 (en) 2011-08-03 2016-01-05 Portland State University Fluorescence detection of cysteine and homocysteine
DE102012004132A1 (en) 2012-02-29 2013-08-29 Friedrich-Schiller-Universität Jena Carbon monoxide-releasing materials and their use
US11020334B2 (en) * 2017-02-17 2021-06-01 Illustris Pharmaceuticals, Inc. Compounds, compositions and use thereof
WO2023287931A1 (en) * 2021-07-13 2023-01-19 Conagen Inc. Esters of a retinoid and bakuchiol and preparations thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216224A (en) * 1978-09-22 1980-08-05 Scott Eugene J Van Methods and compositions for treating psoriasis with retinoyl compounds
JPS6163609A (en) * 1984-09-04 1986-04-01 Takasago Corp Inhibitor of tyrosinase activity
JPS61207332A (en) * 1985-03-12 1986-09-13 Nisshin Kagaku Kk Remedy for dermatic disease
US4595696A (en) * 1985-09-13 1986-06-17 Usv Pharmaceutical Corp. Polyene compounds useful in the treatment of allergic responses

Also Published As

Publication number Publication date
KR920700612A (en) 1992-08-10
EP0436010A1 (en) 1991-07-10
JPH04500824A (en) 1992-02-13
WO1991001128A1 (en) 1991-02-07
HU906129D0 (en) 1991-07-29
CA2035459A1 (en) 1991-01-26

Similar Documents

Publication Publication Date Title
HUT49290A (en) Process for producing retarde pharmaceutical compositions
HU896444D0 (en) Process for the preparation of pharmaceutical compositions
HUT50851A (en) Process for producing intervenous pharmaceutical compositions
HUT54046A (en) Process for producing pharmaceutical compositions
HUT50445A (en) Process for producing pharmaceutical compositions suitable for preventing sexual diseases
HU895444D0 (en) Process for the preparation of ophthalmic pharmaceutical composition
HUT58304A (en) Process for producing quinazolin-3-alkane-acids and pharmaceutical compositions containing them
EP0428003A3 (en) Process for the preparation of polyetherglycols
HUT47113A (en) Process for producing 3-(benzopyrano- and -thiopyrano-pyrazolyl)-3-oxo-propionitriles and pharmaceutical compositions comprising the same
HUT54041A (en) Process for producing stable pharmaceutical compositions
HUT53655A (en) Process for producing pharmaceutical compositions suitable for treating hiv-infected patients
HUT50473A (en) Process for producing imidazopyridazinones and pharmaceutical compositions comprising such compounds
HUT48600A (en) Process for producing condensed benzazepine derivatives and pharmaceutical compositions comprising the compounds
HU906358D0 (en) Process for producing nukleosides and pharmaceutical compositions containing them
HUT46644A (en) Process for producing propylophenone derivatives and pharmaceutical compositions comprising the same
HUT48591A (en) Process for producing new fluoromethoxyphenyl-dihydro-pyridines and pharmaceutical compositions comprising these compounds
HUT56264A (en) Process for producing pharmaceutical compositions for external application
HU907129D0 (en) Process for producing pharmaceutical preparatives
HUT55636A (en) Process for producing pharmaceutical composition
HUT57587A (en) Process for producing pharmaceutical compositions having anxiolytic effect
EP0415189A3 (en) Process for the preparation of aminbenzylalcohol
HUT48592A (en) Process for producing new fluoromethoxyphenyl-dihydropyridines and pharmaceutical compositions comprising these compounds
HU896335D0 (en) Process for the preparation of tetrahydropyridine derivatives
HU910729D0 (en) Process for producing pharmaceutical preparatives of anti-progestomime effect
GB2228481B (en) Process for the preparation of lactones

Legal Events

Date Code Title Description
DFD9 Temporary prot. cancelled due to non-payment of fee